Fable Therapeutics
- Headquarters
- Cambridge
- Business Model
- B2B
- Website
- fabletherapeutics.com
- Last Round
- Series AOct 2024
- Rounds
- 2
About
Fable Therapeutics applies advanced machine learning and computational protein design to develop novel therapeutics for obesity and cardiometabolic disease. The team includes veteran biotech executives and protein engineers, including scientists trained in Nobel laureate David Baker's protein-design lab at the University of Washington, and is backed by investors such as Versant Ventures and DCVC.
Summary
Fable Therapeutics is an Artificial Intelligence company based in Cambridge. Its most recent funding was a Series A round in Oct 2024. Investors include DCVC (Data Collab), Versant Ventures and Omega Funds.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2024
Sign up to see all 2 events
Funding: Series A through Seed. Amounts, valuations, and investors where available.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/fable-therapeutics"><img src="https://indexed.vc/api/badge/company/fable-therapeutics" alt="Fable Therapeutics on Indexed.vc" width="260" height="76" /></a>